Here we come, ESGCT 2023!
Access to current diagnostic and treatment information is limited for experts and payers.
Read more >
Second poster ESGCT 2023
Can we get more effective?
Read more >
Did you know that over 1000 patients in Central and Eastern Europe benefit from CGT? We would like to share our findings about cell & gene therapy (CGT) use among neurologists and revision physicians in Slovakia and Czechia, which will be presented at ESC
Join Us at ESCGT 2023 in Brussels and we can discuss these findings!
Read more >
Our 2 publication are in Vox Pediatriae, top pediatric research press, focusing on Childhood Obesity!
Prevention and targeted treatment of overweight should therefore become a priority in children‘s health care.
Read more >
Two Abstracts Accepted for ESGCT 2023 in Brussels!
Join us at ESGCT 2023 in Brussels, Belgium.
Read more >
An incredible journey of generations in Jerusalem!
With diverse experiences spanning decades, we explored the crossroads of medicine and history in this ancient city.
Read more >
It was a pleasure to present our poster!
Thank you for opportunity to engage discussions and connect with fellow researchers.
Read more >
SSIEM 2023
Just a one day until SSIEM 2023 Annual Symposium in Israel!
Read more >
For send a poster please contact us:
Read more >
Would you like to meet us at SSIEM 2023 in Jerusalem?
Cell & gene therapy is a real treatment option when processes are handled by an experienced team.
Read more >
Metachromatická leukodystrofie (MLD) - 2
Approved gene therapies as of Q1 2023
Read more >
Metachromatická leukodystrofie (MLD)
Podmínkou indikace genové terapie je včasná diagnostika
Read more >
World EPA Congress 2023
Let’s meet up and discuss what are your ambitions!
Read more >
Advanced Therapies congress 2023
Today is the day!
Read more >
Witnessing the innovation turning into practice is amazing!
It is fullfiling to be a part of the treatment solution team.
Read more >
Which cell&gene therapy congress would you recommend?
We are trying to select the congress with late-stage cell&gene products in development.
Read more >
Special needs for distribution in rare? Talk to us.
Medasol Europe has established cooperation across the EU market with leading pharma distributors permitting us to provide complex distribution support.
Read more >
What do you do to gain new experiences and perspectives?
Some experience is non-transferable
Read more >
Nobel prizes 2022
We would like to congratulate to all nominees and awardees of the Nobel Prize 2022.
Read more >
Is an established company a ticket for successful launch in innovations?
During WODC it was presented that 55 % of large pharma companies miss their launch targets.
Read more >
First patient in CEE with granted cost approval
Follow the story of a nine months old boy on his way to genetic therapy.
Read more >
Patient finding activities: A challenge for innovative companies
Are you a life science company? Do you have a product available for the treatment of an orphan disease? How do you find patient finding activities effective?
Read more >
How to find a patient for a rare disease therapy?
Rare diseases and patient finding activities. Sometimes, as in our case, all stakeholders come to a consensus about patient number potential that is very low. How to proceed?
Read more >
Holoclar® treatment continues in Czech Republic
After introduction in early 2021, Holoclar® therapy has found its way to more patients. Surgeons across the Republic are performing this high-tech surgery in the specialized center in Brno.
Read more >


Medasol s. r. o.
Drtinova 10
150 00 Praha 5

Registration address:
U poštovky 1269/2
150 00 Praha 5

+420 724 333 313